Black Rock Inc. Sensei Biotherapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,777 shares of SNSE stock, worth $3,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,777
Previous 33,582
76.84%
Holding current value
$3,732
Previous $35,000
88.57%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SNSE
# of Institutions
26Shares Held
2.39MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$311,9820.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$285,3370.0% of portfolio
-
Catalio Capital Management, LP New York, NY294KShares$141,2990.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$82,9430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$75,2640.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.7M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...